Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Study protocol

Effectiveness of a structured motivational intervention including smoking cessation advice and spirometry information in the primary care setting: the ESPITAP study

Authors: Francisco Martin-Lujan, Josep Ll Piñol-Moreso, Nuria Martin-Vergara, Josep Basora-Gallisa, Irene Pascual-Palacios, Ramon Sagarra-Alamo, Estefania Aparicio Llopis, Maria T Basora-Gallisa, Roser Pedret-Llaberia, the ESPITAP Study Group investigators

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

There is current controversy about the efficacy of smoking cessation interventions that are based on information obtained by spirometry. The objective of this study is to evaluate the effectiveness in the primary care setting of structured motivational intervention to achieve smoking cessation, compared with usual clinical practice.

Methods

Design

Multicentre randomized clinical trial with an intervention and a control group.

Setting

12 primary care centres in the province of Tarragona (Spain).

Subjects of study

600 current smokers aged between 35 and 70 years with a cumulative habit of more than 10 packs of cigarettes per year, attended in primary care for any reason and who did not meet any of the exclusion criteria for the study, randomly assigned to structured intervention or standard clinical attention.

Intervention

Usual advice to quit smoking by a general practitioner as well as a 20-minute personalized visit to provide detailed information about spirometry results, during which FEV1, FVC, FEF 25-75% and PEF measurements were discussed and interpreted in terms of theoretical values. Additional information included the lung age index (defined as the average age of a non-smoker with the same FEV1 as the study participant), comparing this with the chronological age to illustrate the pulmonary deterioration that results from smoking.

Measurements

Spirometry during the initial visit. Structured interview questionnaire administered at the primary care centre at the initial visit and at 12-month follow-up. Telephone follow-up interview at 6 months. At 12-month follow-up, expired CO was measured in patients who claimed to have quit smoking.

Main variables

Smoking cessation at 12 months.

Analysis

Data will be analyzed on the basis of "intention to treat" and the unit of analysis will be the individual smoker.

Expected results

Among active smokers treated in primary care we anticipate significantly higher smoking cessation in the intervention group than in the control group.

Discussion

Application of a motivational intervention based on structured information about spirometry results, improved abstinence rates among smokers seen in actual clinical practice conditions in primary care.

Trial registration

ClinicalTrial.gov, number NCT01194596.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. 2010, [http://www.goldcopd.org/]Reviewed Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. 2010, [http://​www.​goldcopd.​org/​]Reviewed
2.
go back to reference Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB: The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009, 180: 3-10. 10.1164/rccm.200901-0047OC.CrossRefPubMed Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB: The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009, 180: 3-10. 10.1164/rccm.200901-0047OC.CrossRefPubMed
3.
go back to reference Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J: Developing COPD: a 25 year follow up study of the general population. Thorax. 2006, 61: 935-939. 10.1136/thx.2006.062802.CrossRefPubMedPubMedCentral Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J: Developing COPD: a 25 year follow up study of the general population. Thorax. 2006, 61: 935-939. 10.1136/thx.2006.062802.CrossRefPubMedPubMedCentral
4.
go back to reference Raherison C, Girodet PO: Epidemiology of COPD. Eur Respir Rev. 2009, 18: 213-221. 10.1183/09059180.00003609.CrossRefPubMed Raherison C, Girodet PO: Epidemiology of COPD. Eur Respir Rev. 2009, 18: 213-221. 10.1183/09059180.00003609.CrossRefPubMed
5.
go back to reference Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001, 163: 1256-1276.CrossRefPubMed Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001, 163: 1256-1276.CrossRefPubMed
6.
go back to reference Peces-Barba G, Barberà JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardim J, López Varela V, Monsó E, Montemayor T, Viejo JL: Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT). Arch Bronconeumol. 2008, 44: 271-281.CrossRefPubMed Peces-Barba G, Barberà JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardim J, López Varela V, Monsó E, Montemayor T, Viejo JL: Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT). Arch Bronconeumol. 2008, 44: 271-281.CrossRefPubMed
7.
go back to reference United States Preventive Services Task Force: Screening for chronic obstructive pulmonary disease using spirometry: US preventive services Task Force recommendation statement. Ann Intern Med. 2008, 148: 529-533.CrossRef United States Preventive Services Task Force: Screening for chronic obstructive pulmonary disease using spirometry: US preventive services Task Force recommendation statement. Ann Intern Med. 2008, 148: 529-533.CrossRef
8.
go back to reference Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB: Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008, 148: 535-543.CrossRefPubMed Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB: Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008, 148: 535-543.CrossRefPubMed
9.
go back to reference Whitlock EP, Orleans CT, Pender N, Allan J: Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med. 2002, 22: 267-284. 10.1016/S0749-3797(02)00415-4.CrossRefPubMed Whitlock EP, Orleans CT, Pender N, Allan J: Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med. 2002, 22: 267-284. 10.1016/S0749-3797(02)00415-4.CrossRefPubMed
10.
go back to reference Cornuz J, Willi C: Non-pharmacological smoking cessation interventions in clinical practice. Eur Respir Rev. 2008, 17: 187-191. 10.1183/09059180.00011003.CrossRef Cornuz J, Willi C: Non-pharmacological smoking cessation interventions in clinical practice. Eur Respir Rev. 2008, 17: 187-191. 10.1183/09059180.00011003.CrossRef
11.
go back to reference Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP: Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax. 2010, 65: 711-718. 10.1136/thx.2009.131631.CrossRefPubMed Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP: Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax. 2010, 65: 711-718. 10.1136/thx.2009.131631.CrossRefPubMed
12.
go back to reference Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman S, Froelicher E, Goldstein M, Healton C, Henderson P, Heyman R, Koh H, Kottke T, Lando H, Mecklenburg R, Mermelstein R, Mullen P, Orleans C, Robinson L, Stitzer M, Tommasello A, Villejo L, Wewers M: Treating tobacco use and dependence: 2008 update. Clinical practice guideline. 2008, Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, [http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf] Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman S, Froelicher E, Goldstein M, Healton C, Henderson P, Heyman R, Koh H, Kottke T, Lando H, Mecklenburg R, Mermelstein R, Mullen P, Orleans C, Robinson L, Stitzer M, Tommasello A, Villejo L, Wewers M: Treating tobacco use and dependence: 2008 update. Clinical practice guideline. 2008, Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, [http://​www.​surgeongeneral.​gov/​tobacco/​treating_​tobacco_​use08.​pdf]
13.
go back to reference Ferguson GT, Enright PL, Buist AS, Higgins MW: Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000, 117: 1146-1161. 10.1378/chest.117.4.1146.CrossRefPubMed Ferguson GT, Enright PL, Buist AS, Higgins MW: Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000, 117: 1146-1161. 10.1378/chest.117.4.1146.CrossRefPubMed
14.
go back to reference Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O'Hara P: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994, 272: 1497-1505. 10.1001/jama.272.19.1497.CrossRefPubMed Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O'Hara P: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994, 272: 1497-1505. 10.1001/jama.272.19.1497.CrossRefPubMed
15.
go back to reference Anthonisen NR, Connett JE, Murray RP: Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002, 166: 675-679. 10.1164/rccm.2112096.CrossRefPubMed Anthonisen NR, Connett JE, Murray RP: Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002, 166: 675-679. 10.1164/rccm.2112096.CrossRefPubMed
16.
go back to reference Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE: Bronchodilator response in the lung health study over 11 years. Eur Respir J. 2005, 1: 45-51.CrossRef Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE: Bronchodilator response in the lung health study over 11 years. Eur Respir J. 2005, 1: 45-51.CrossRef
17.
go back to reference Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, Jasionowicz M, Bijata-Bronisz R, Lempicka-Jastrzebska M, Czajkowski M, Przybylski G, Zielinski J: Smokers with airway obstruction are more likely to quit smoking. Thorax. 2006, 61: 869-873. 10.1136/thx.2006.059071.CrossRefPubMedPubMedCentral Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, Jasionowicz M, Bijata-Bronisz R, Lempicka-Jastrzebska M, Czajkowski M, Przybylski G, Zielinski J: Smokers with airway obstruction are more likely to quit smoking. Thorax. 2006, 61: 869-873. 10.1136/thx.2006.059071.CrossRefPubMedPubMedCentral
19.
go back to reference Boushey H, Enright P, Samet J: Spirometry for chronic obstructive pulmonary disease case finding in primary care?. Am J Respir Crit Care Med. 2005, 172: 1481-1482. 10.1164/rccm.2509009.CrossRefPubMed Boushey H, Enright P, Samet J: Spirometry for chronic obstructive pulmonary disease case finding in primary care?. Am J Respir Crit Care Med. 2005, 172: 1481-1482. 10.1164/rccm.2509009.CrossRefPubMed
20.
go back to reference Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM: Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res. 2007, 9: 21-32. 10.1080/14622200601078509.CrossRefPubMed Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM: Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res. 2007, 9: 21-32. 10.1080/14622200601078509.CrossRefPubMed
21.
go back to reference Bize R, Burnand B, Mueller Y, Rège Walther M, Cornuz J: Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2009, CD004705-2 Bize R, Burnand B, Mueller Y, Rège Walther M, Cornuz J: Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2009, CD004705-2
22.
go back to reference Parkes G, Greenhalgh T, Griffin M, Dent R: Effect of smoking on quit rate of telling patients their lung age: the Step2quit randomized controlled trial. BMJ. 2008, 336: 598-600. 10.1136/bmj.39503.582396.25.CrossRefPubMedPubMedCentral Parkes G, Greenhalgh T, Griffin M, Dent R: Effect of smoking on quit rate of telling patients their lung age: the Step2quit randomized controlled trial. BMJ. 2008, 336: 598-600. 10.1136/bmj.39503.582396.25.CrossRefPubMedPubMedCentral
23.
go back to reference Kotz D, Wesseling G, Huibers MJH, van Schayck OCP: Efficacy of confronting smokers with airflow limitation for smoking cessation. Eur Respir J. 2009, 33: 754-762. 10.1183/09031936.00116308.CrossRefPubMed Kotz D, Wesseling G, Huibers MJH, van Schayck OCP: Efficacy of confronting smokers with airflow limitation for smoking cessation. Eur Respir J. 2009, 33: 754-762. 10.1183/09031936.00116308.CrossRefPubMed
24.
go back to reference McClure JB, Ludman EJ, Grothaus L, Pabiniak C, Richards J: Impact of a brief motivational smoking cessation intervention: the Get PHIT trial. Am J Prev Med. 2009, 37: 116-123. 10.1016/j.amepre.2009.03.018.CrossRefPubMedPubMedCentral McClure JB, Ludman EJ, Grothaus L, Pabiniak C, Richards J: Impact of a brief motivational smoking cessation intervention: the Get PHIT trial. Am J Prev Med. 2009, 37: 116-123. 10.1016/j.amepre.2009.03.018.CrossRefPubMedPubMedCentral
25.
go back to reference McClure JB, Ludman EJ, Grothaus L, Pabiniak C, Richards J: Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: a comparison of smokers with and without lung impairment. Patient Educ Couns. 2010, 80: 280-283. 10.1016/j.pec.2009.11.002.CrossRefPubMedPubMedCentral McClure JB, Ludman EJ, Grothaus L, Pabiniak C, Richards J: Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: a comparison of smokers with and without lung impairment. Patient Educ Couns. 2010, 80: 280-283. 10.1016/j.pec.2009.11.002.CrossRefPubMedPubMedCentral
26.
go back to reference Heatherton TF, Kozlowski LT, Frecker RC, Fageström KO: The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991, 86: 1119-1127. 10.1111/j.1360-0443.1991.tb01879.x.CrossRefPubMed Heatherton TF, Kozlowski LT, Frecker RC, Fageström KO: The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991, 86: 1119-1127. 10.1111/j.1360-0443.1991.tb01879.x.CrossRefPubMed
27.
go back to reference Richmond RL, Kehoe LA, Webster IW: Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction. 1993, 88: 1127-1135. 10.1111/j.1360-0443.1993.tb02132.x.CrossRefPubMed Richmond RL, Kehoe LA, Webster IW: Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction. 1993, 88: 1127-1135. 10.1111/j.1360-0443.1993.tb02132.x.CrossRefPubMed
28.
go back to reference Prochaska JO, DiClemente CC: Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983, 51: 390-395.CrossRefPubMed Prochaska JO, DiClemente CC: Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983, 51: 390-395.CrossRefPubMed
29.
go back to reference Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: General considerations for lung function testing. Eur Respir J. 2005, 26: 153-161. 10.1183/09031936.05.00034505.CrossRefPubMed Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: General considerations for lung function testing. Eur Respir J. 2005, 26: 153-161. 10.1183/09031936.05.00034505.CrossRefPubMed
30.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed
31.
go back to reference Martín F, Donado-Mazarrón A, Basora J, Daniel J: Pruebas funcionales respiratorias en atención primaria. Interpretación informatizada de espirometrías. Form Med Contin Aten Prim. 1999, 6: 161-172. Martín F, Donado-Mazarrón A, Basora J, Daniel J: Pruebas funcionales respiratorias en atención primaria. Interpretación informatizada de espirometrías. Form Med Contin Aten Prim. 1999, 6: 161-172.
32.
go back to reference Stead LF, Bergson G, Lancaster T: Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008, CD000165- Stead LF, Bergson G, Lancaster T: Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008, CD000165-
33.
go back to reference Morris JF, Temple W: Spirometric "lung age" estimation for motivating smoking cessation. Prev Med. 1985, 14: 655-662. 10.1016/0091-7435(85)90085-4.CrossRefPubMed Morris JF, Temple W: Spirometric "lung age" estimation for motivating smoking cessation. Prev Med. 1985, 14: 655-662. 10.1016/0091-7435(85)90085-4.CrossRefPubMed
34.
go back to reference Sato S, Nishimura K, Koyama H, Tsukino M, Oga T, Hajiro T, Mishima M: Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest. 2003, 124: 1749-54. 10.1378/chest.124.5.1749.CrossRefPubMed Sato S, Nishimura K, Koyama H, Tsukino M, Oga T, Hajiro T, Mishima M: Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest. 2003, 124: 1749-54. 10.1378/chest.124.5.1749.CrossRefPubMed
35.
go back to reference Hughes J, Keely J, Niaura R, Ossip-Klein D, Richmond R, Swan G: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003, 5: 13-26.CrossRefPubMed Hughes J, Keely J, Niaura R, Ossip-Klein D, Richmond R, Swan G: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003, 5: 13-26.CrossRefPubMed
36.
go back to reference Caponnetto P, Polosa R: Common predictors of smoking cessation in clinical practice. Respir Med. 2008, 102: 1182-1192. 10.1016/j.rmed.2008.02.017.CrossRefPubMed Caponnetto P, Polosa R: Common predictors of smoking cessation in clinical practice. Respir Med. 2008, 102: 1182-1192. 10.1016/j.rmed.2008.02.017.CrossRefPubMed
37.
go back to reference Aveyard P, Brown K, Saunders C, Alexander A, Johnstone E, Munafò MR, Murphy M: Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax. 2007, 62: 898-903. 10.1136/thx.2006.071837.CrossRefPubMedPubMedCentral Aveyard P, Brown K, Saunders C, Alexander A, Johnstone E, Munafò MR, Murphy M: Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax. 2007, 62: 898-903. 10.1136/thx.2006.071837.CrossRefPubMedPubMedCentral
Metadata
Title
Effectiveness of a structured motivational intervention including smoking cessation advice and spirometry information in the primary care setting: the ESPITAP study
Authors
Francisco Martin-Lujan
Josep Ll Piñol-Moreso
Nuria Martin-Vergara
Josep Basora-Gallisa
Irene Pascual-Palacios
Ramon Sagarra-Alamo
Estefania Aparicio Llopis
Maria T Basora-Gallisa
Roser Pedret-Llaberia
the ESPITAP Study Group investigators
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-859

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue